@article{df730b51adca4da2a9b75d08fa1f1650,
title = "Fragile X syndrome",
abstract = "Paul Hagerman and Randi Hagerman introduce the X-linked neurodevelopmental disorder Fragile X syndrome (FXS) and discuss what causes this disorder and how it can be treated.",
author = "Hagerman, {Paul J.} and Randi Hagerman",
note = "Funding Information: P.J.H. is a member of the Scientific Advisory Board of NeuCyte Pharmaceuticals, Inc. R.H. is a member of the Scientific and Clinical advisory committee of the National Fragile X Foundation (NFXF). R.H. is also on the Clinical Treatments Committee of the NFXF. R.H. is on the Tetra Advisory Committee and the Zynerba Scientific Advisory Committee. Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",
year = "2021",
month = mar,
day = "22",
doi = "10.1016/j.cub.2021.01.043",
language = "English (US)",
volume = "31",
pages = "R273--R275",
journal = "Current Biology",
issn = "0960-9822",
publisher = "Cell Press",
number = "6",
}